Inhibikase Therapeutics, Inc. (IKT) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$1.60
+1.59%
Mkt Cap $238.61M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 May 12, 2026 | — | — | — | — | -$0.10 | — |
| Q1 2026 Mar 26, 2026 | — | — | — | -$0.12 | -$0.09 | +25.00% |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.13 | -$0.13 | +0.00% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.09 | -$0.11 | -22.22% |
| Q2 2025 May 14, 2025 | — | — | — | -$0.11 | -$0.15 | -36.36% |
| Q1 2025 Mar 26, 2025 | — | — | — | -$0.10 | -$0.63 | -530.00% |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.38 | -$0.65 | -71.05% |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.58 | -$0.66 | -13.79% |
| Q2 2024 May 15, 2024 | — | — | — | -$0.79 | -$0.73 | +7.59% |
| Q1 2024 Mar 27, 2024 | — | $1 | — | -$0.78 | -$0.63 | +19.23% |
| Q4 2023 Nov 14, 2023 | — | $79.57K | — | -$1.12 | -$0.86 | +23.21% |
| Q3 2023 Aug 14, 2023 | — | $116.41K | — | -$0.92 | -$1.11 | -20.65% |
| Q1 2023 Mar 31, 2023 | — | $64.52K | — | -$0.14 | -$1.02 | -628.57% |
| Q1 2023 Mar 30, 2023 | — | $123.44K | — | — | -$0.20 | — |
| Q4 2022 Nov 14, 2022 | $200.00K | $7.29K | -96.35% | -$0.18 | -$1.08 | -500.00% |
| Q3 2022 Aug 12, 2022 | $300.00K | $6.55K | -97.82% | -$0.19 | -$1.08 | -468.42% |
| Q2 2022 May 16, 2022 | $300.00K | $46.03K | -84.66% | -$0.17 | -$1.08 | -535.29% |
| Q1 2022 Mar 31, 2022 | $300.00K | $1.94K | -99.35% | -$0.17 | -$1.20 | -605.88% |
| Q4 2021 Nov 15, 2021 | $300.00K | $328.46K | +9.49% | -$0.14 | -$1.08 | -671.43% |
| Q3 2021 Aug 16, 2021 | $300.00K | $1.36M | +354.35% | -$0.38 | -$1.32 | -247.37% |
| Q2 2021 May 17, 2021 | — | $1.41M | — | — | -$1.56 | — |
| Q1 2021 Mar 31, 2021 | — | $698.47K | — | — | -$0.87 | — |
| Q3 2020 Sep 30, 2020 | — | $37.68K | — | — | -$0.49 | — |
| Q2 2020 Jun 30, 2020 | — | $219.59K | — | — | -$0.31 | — |
| Q1 2020 Mar 31, 2020 | — | $270.79K | — | — | -$0.40 | — |
| Q4 2019 Dec 31, 2019 | — | $240.28K | — | — | -$0.32 | — |
| Q3 2019 Sep 30, 2019 | — | $124.43K | — | — | -$0.89 | — |
| Q2 2019 Jun 30, 2019 | — | $166.93K | — | — | -$1.72 | — |
| Q1 2019 Mar 31, 2019 | — | $591.10K | — | — | -$1.27 | — |
| Q4 2018 Dec 31, 2018 | — | $1.35M | — | — | -$0.74 | — |
| Q1 2018 Mar 31, 2018 | — | $691.20K | — | — | -$0.10 | — |
| Q4 2017 Dec 31, 2017 | — | $797.40K | — | — | $0.03 | — |
| Q1 2017 Mar 31, 2017 | — | $247.38K | — | — | -$0.14 | — |